SANUWAVE Health is a high-energy, acoustic shock wave technology company initially focused on the development and commercialization of patented, non-invasive biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It intends to apply its patented PACE technology in wound healing, orthopedic/spine, plastic/cosmetic, and cardiac conditions.
The company reported today that pre-clinical results using its PACE technology were presented to the 2013 World Congress of Microsurgery by Dr. Maria Siemionow. She is a world-renowned scientist and microsurgeon and is the director of plastic surgery research and of microsurgical training at Cleveland Clinic's department of plastic surgery. Her specialties are: microsurgery, hand surgery, peripheral nerve surgery, transplantation, and microcirculation research.
The results showed that the application of its lead product candidate for the wound care market, dermaPACE, appeared to significantly decrease the inflammation and tissue damage that typically occurs when blood flow is interrupted during microsurgical procedures. A prolonged cutoff of blood supply occurs during complex microsurgical procedures. This can lead to serious, post-operative complications including muscle damage and tissue necrosis.
SANUWAVE's dermaPACE addresses these possible complications. Dr. Siemionow said, "If these [pre-clinical] results hold true in further investigations, such an effect should lead to quicker and more complete tissue healing in a variety of medical and surgical settings." In other words, reducing inflammation through the use of PACE treatments could provide benefits to both patients and doctors.
For more information about SANUWAVE Health and its product line revolving around its patented PACE technology, please visit sanuwave.com
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.